The Valley Desk

NCT06161571 · Interventional trial

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Overall registry status Active not recruiting

Phase 3

Conditions NAFLD/MASLD, NASH/MASH

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov